[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BarnyardBull72 David David posts on X about $lexx, $nvo, $lly, $pfe the most. They currently have XXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1861792290349658112/interactions)  - X Week XXXXX +394% - X Month XXXXX -XX% - X Months XXXXXXX +70,297% ### Mentions: X [#](/creator/twitter::1861792290349658112/posts_active)  - X Week X no change - X Month XX -XX% - X Months XXX +3,867% ### Followers: XXX [#](/creator/twitter::1861792290349658112/followers)  - X Week XXX +3.70% - X Month XXX +10% - X Months XXX +13,800% ### CreatorRank: undefined [#](/creator/twitter::1861792290349658112/influencer_rank)  ### Social Influence [#](/creator/twitter::1861792290349658112/influence) --- **Social category influence** [stocks](/list/stocks) [finance](/list/finance) **Social topic influence** [$lexx](/topic/$lexx) #1, [$nvo](/topic/$nvo), [$lly](/topic/$lly), [$pfe](/topic/$pfe), [discussions](/topic/discussions), [unlimited](/topic/unlimited), [mta](/topic/mta) **Top assets mentioned** [Novo-Nordisk (NVO)](/topic/$nvo) [Eli Lilly and Company (LLY)](/topic/$lly) [Pfizer, Inc. (PFE)](/topic/$pfe) ### Top Social Posts [#](/creator/twitter::1861792290349658112/posts) --- Top posts by engagements in the last XX hours "$LEXX Facts: -Human trial readout coming Nov/Dec -Currently in MTA with global pharma ( $NVO $LLY $PFE ) -Recently hired BD firm for discussions with multiple pharma groups" [X Link](https://x.com/BarnyardBull72/status/1978960074635698456) [@BarnyardBull72](/creator/x/BarnyardBull72) 2025-10-16T23:03Z XXX followers, XXX engagements "🔍 Great breakdown on $LEXX from @ChartsRUs0 most people still dont realize this is a true platform play in GLP-1 oral delivery not a one-off trial. Human data readout expected Q4 XX could be transformative if it validates across the class. Still trading at micro-cap levels. -Dont forget about the MTA currently signed with a global pharma company" [X Link](https://x.com/BarnyardBull72/status/1977438950123057619) [@BarnyardBull72](/creator/x/BarnyardBull72) 2025-10-12T18:19Z XXX followers, XXX engagements "$LEXX THE QUIET GIANT ✅ GLP-1 human data readout next month game-changing catalyst ✅ MTA signed with Global Pharma ✅ BD firm engaged to handle inbound pharma interest ✅ Platform tech not a single drug unlimited licensing potential/ buyout lockup ✅ X% nausea in prior semaglutide study massive tolerability edge ✅ Brain delivery data opens Alzheimers door ✅ M&A written all over it Now layer this in: Novo Nordisk just got FDA approval for oral Rybelsus label expansion + has patent pressure + Alzheimers data coming in XX days. They need differentiation. If DehydraTECH makes GLP-1s: Safer ✅ Faster" [X Link](https://x.com/BarnyardBull72/status/1980311700613349476) [@BarnyardBull72](/creator/x/BarnyardBull72) 2025-10-20T16:34Z XXX followers, 1834 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
David posts on X about $lexx, $nvo, $lly, $pfe the most. They currently have XXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Social category influence stocks finance
Social topic influence $lexx #1, $nvo, $lly, $pfe, discussions, unlimited, mta
Top assets mentioned Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Pfizer, Inc. (PFE)
Top posts by engagements in the last XX hours
"$LEXX Facts: -Human trial readout coming Nov/Dec -Currently in MTA with global pharma ( $NVO $LLY $PFE ) -Recently hired BD firm for discussions with multiple pharma groups"
X Link @BarnyardBull72 2025-10-16T23:03Z XXX followers, XXX engagements
"🔍 Great breakdown on $LEXX from @ChartsRUs0 most people still dont realize this is a true platform play in GLP-1 oral delivery not a one-off trial. Human data readout expected Q4 XX could be transformative if it validates across the class. Still trading at micro-cap levels. -Dont forget about the MTA currently signed with a global pharma company"
X Link @BarnyardBull72 2025-10-12T18:19Z XXX followers, XXX engagements
"$LEXX THE QUIET GIANT ✅ GLP-1 human data readout next month game-changing catalyst ✅ MTA signed with Global Pharma ✅ BD firm engaged to handle inbound pharma interest ✅ Platform tech not a single drug unlimited licensing potential/ buyout lockup ✅ X% nausea in prior semaglutide study massive tolerability edge ✅ Brain delivery data opens Alzheimers door ✅ M&A written all over it Now layer this in: Novo Nordisk just got FDA approval for oral Rybelsus label expansion + has patent pressure + Alzheimers data coming in XX days. They need differentiation. If DehydraTECH makes GLP-1s: Safer ✅ Faster"
X Link @BarnyardBull72 2025-10-20T16:34Z XXX followers, 1834 engagements
/creator/twitter::BarnyardBull72